Machine Learning Uses Chemo-Transcriptomic Profiles to Stratify Antimalarial Compounds With Similar Mode of Action
The rapid development of antimalarial resistance motivates the continued search for novel compounds with a mode of action (MoA) different to current antimalarials. Phenotypic screening has delivered thousands of promising hit compounds without prior knowledge of the compounds’ exact target or MoA. W...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2021.688256/full |
id |
doaj-e0f47790a3474225adad2c7016b58e7c |
---|---|
record_format |
Article |
spelling |
doaj-e0f47790a3474225adad2c7016b58e7c2021-06-29T07:14:31ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882021-06-011110.3389/fcimb.2021.688256688256Machine Learning Uses Chemo-Transcriptomic Profiles to Stratify Antimalarial Compounds With Similar Mode of ActionAshleigh van Heerden0Ashleigh van Heerden1Roelof van Wyk2Roelof van Wyk3Lyn-Marie Birkholtz4Lyn-Marie Birkholtz5Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Hatfield, South AfricaUniversity of Pretoria Institute for Sustainable Malaria Control, University of Pretoria, Hatfield, South AfricaDepartment of Biochemistry, Genetics and Microbiology, University of Pretoria, Hatfield, South AfricaUniversity of Pretoria Institute for Sustainable Malaria Control, University of Pretoria, Hatfield, South AfricaDepartment of Biochemistry, Genetics and Microbiology, University of Pretoria, Hatfield, South AfricaUniversity of Pretoria Institute for Sustainable Malaria Control, University of Pretoria, Hatfield, South AfricaThe rapid development of antimalarial resistance motivates the continued search for novel compounds with a mode of action (MoA) different to current antimalarials. Phenotypic screening has delivered thousands of promising hit compounds without prior knowledge of the compounds’ exact target or MoA. Whilst the latter is not initially required to progress a compound in a medicinal chemistry program, identifying the MoA early can accelerate hit prioritization, hit-to-lead optimization and preclinical combination studies in malaria research. The effects of drug treatment on a cell can be observed on systems level in changes in the transcriptome, proteome and metabolome. Machine learning (ML) algorithms are powerful tools able to deconvolute such complex chemically-induced transcriptional signatures to identify pathways on which a compound act and in this manner provide an indication of the MoA of a compound. In this study, we assessed different ML approaches for their ability to stratify antimalarial compounds based on varied chemically-induced transcriptional responses. We developed a rational gene selection approach that could identify predictive features for MoA to train and generate ML models. The best performing model could stratify compounds with similar MoA with a classification accuracy of 76.6 ± 6.4%. Moreover, only a limited set of 50 biomarkers was required to stratify compounds with similar MoA and define chemo-transcriptomic fingerprints for each compound. These fingerprints were unique for each compound and compounds with similar targets/MoA clustered together. The ML model was specific and sensitive enough to group new compounds into MoAs associated with their predicted target and was robust enough to be extended to also generate chemo-transcriptomic fingerprints for additional life cycle stages like immature gametocytes. This work therefore contributes a new strategy to rapidly, specifically and sensitively indicate the MoA of compounds based on chemo-transcriptomic fingerprints and holds promise to accelerate antimalarial drug discovery programs.https://www.frontiersin.org/articles/10.3389/fcimb.2021.688256/fullmachine learningmode of actiongene expression profilebiomarkermultinominal logistic regressionchemo-transcriptomic fingerprint |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ashleigh van Heerden Ashleigh van Heerden Roelof van Wyk Roelof van Wyk Lyn-Marie Birkholtz Lyn-Marie Birkholtz |
spellingShingle |
Ashleigh van Heerden Ashleigh van Heerden Roelof van Wyk Roelof van Wyk Lyn-Marie Birkholtz Lyn-Marie Birkholtz Machine Learning Uses Chemo-Transcriptomic Profiles to Stratify Antimalarial Compounds With Similar Mode of Action Frontiers in Cellular and Infection Microbiology machine learning mode of action gene expression profile biomarker multinominal logistic regression chemo-transcriptomic fingerprint |
author_facet |
Ashleigh van Heerden Ashleigh van Heerden Roelof van Wyk Roelof van Wyk Lyn-Marie Birkholtz Lyn-Marie Birkholtz |
author_sort |
Ashleigh van Heerden |
title |
Machine Learning Uses Chemo-Transcriptomic Profiles to Stratify Antimalarial Compounds With Similar Mode of Action |
title_short |
Machine Learning Uses Chemo-Transcriptomic Profiles to Stratify Antimalarial Compounds With Similar Mode of Action |
title_full |
Machine Learning Uses Chemo-Transcriptomic Profiles to Stratify Antimalarial Compounds With Similar Mode of Action |
title_fullStr |
Machine Learning Uses Chemo-Transcriptomic Profiles to Stratify Antimalarial Compounds With Similar Mode of Action |
title_full_unstemmed |
Machine Learning Uses Chemo-Transcriptomic Profiles to Stratify Antimalarial Compounds With Similar Mode of Action |
title_sort |
machine learning uses chemo-transcriptomic profiles to stratify antimalarial compounds with similar mode of action |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Cellular and Infection Microbiology |
issn |
2235-2988 |
publishDate |
2021-06-01 |
description |
The rapid development of antimalarial resistance motivates the continued search for novel compounds with a mode of action (MoA) different to current antimalarials. Phenotypic screening has delivered thousands of promising hit compounds without prior knowledge of the compounds’ exact target or MoA. Whilst the latter is not initially required to progress a compound in a medicinal chemistry program, identifying the MoA early can accelerate hit prioritization, hit-to-lead optimization and preclinical combination studies in malaria research. The effects of drug treatment on a cell can be observed on systems level in changes in the transcriptome, proteome and metabolome. Machine learning (ML) algorithms are powerful tools able to deconvolute such complex chemically-induced transcriptional signatures to identify pathways on which a compound act and in this manner provide an indication of the MoA of a compound. In this study, we assessed different ML approaches for their ability to stratify antimalarial compounds based on varied chemically-induced transcriptional responses. We developed a rational gene selection approach that could identify predictive features for MoA to train and generate ML models. The best performing model could stratify compounds with similar MoA with a classification accuracy of 76.6 ± 6.4%. Moreover, only a limited set of 50 biomarkers was required to stratify compounds with similar MoA and define chemo-transcriptomic fingerprints for each compound. These fingerprints were unique for each compound and compounds with similar targets/MoA clustered together. The ML model was specific and sensitive enough to group new compounds into MoAs associated with their predicted target and was robust enough to be extended to also generate chemo-transcriptomic fingerprints for additional life cycle stages like immature gametocytes. This work therefore contributes a new strategy to rapidly, specifically and sensitively indicate the MoA of compounds based on chemo-transcriptomic fingerprints and holds promise to accelerate antimalarial drug discovery programs. |
topic |
machine learning mode of action gene expression profile biomarker multinominal logistic regression chemo-transcriptomic fingerprint |
url |
https://www.frontiersin.org/articles/10.3389/fcimb.2021.688256/full |
work_keys_str_mv |
AT ashleighvanheerden machinelearninguseschemotranscriptomicprofilestostratifyantimalarialcompoundswithsimilarmodeofaction AT ashleighvanheerden machinelearninguseschemotranscriptomicprofilestostratifyantimalarialcompoundswithsimilarmodeofaction AT roelofvanwyk machinelearninguseschemotranscriptomicprofilestostratifyantimalarialcompoundswithsimilarmodeofaction AT roelofvanwyk machinelearninguseschemotranscriptomicprofilestostratifyantimalarialcompoundswithsimilarmodeofaction AT lynmariebirkholtz machinelearninguseschemotranscriptomicprofilestostratifyantimalarialcompoundswithsimilarmodeofaction AT lynmariebirkholtz machinelearninguseschemotranscriptomicprofilestostratifyantimalarialcompoundswithsimilarmodeofaction |
_version_ |
1721355474712920064 |